BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38704374)

  • 21. A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.
    Lo B; Ramaswamy M; Davis J; Price S; Rao VK; Siegel RM; Lenardo MJ
    J Clin Immunol; 2013 Feb; 33(2):479-88. PubMed ID: 23054345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
    Marega LF; Teocchi MA; Dos Santos Vilela MM
    Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
    Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
    Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in FAS and CASP8 genes may contribute to the development of ALPS phenotype: a study in 25 patients with probable ALPS.
    Tan Ç; Özgül RK; Çağdaş Ayvaz D; Tezcan İ; Sanal Ö
    Turk J Pediatr; 2015; 57(2):141-5. PubMed ID: 26690594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
    Consonni F; Gambineri E; Favre C
    Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
    Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
    Front Immunol; 2019; 10():1193. PubMed ID: 31191551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
    Dowdell KC; Niemela JE; Price S; Davis J; Hornung RL; Oliveira JB; Puck JM; Jaffe ES; Pittaluga S; Cohen JI; Fleisher TA; Rao VK
    Blood; 2010 Jun; 115(25):5164-9. PubMed ID: 20360470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
    Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
    Front Immunol; 2018; 9():718. PubMed ID: 29686686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.
    Aberdein D; Munday JS; Gandolfi B; Dittmer KE; Malik R; Garrick DJ; Lyons LA;
    Mamm Genome; 2017 Feb; 28(1-2):47-55. PubMed ID: 27770190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic landscape of the FAS pathway deficiencies.
    Magerus A; Bercher-Brayer C; Rieux-Laucat F
    Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scaling the tips of the ALPS.
    Rieux-Laucat F; Kanellopoulos JM; Ojcius DM
    Biomed J; 2021 Aug; 44(4):383-387. PubMed ID: 34438083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
    Li P; Huang P; Yang Y; Hao M; Peng H; Li F
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
    Hsu AP; Dowdell KC; Davis J; Niemela JE; Anderson SM; Shaw PA; Rao VK; Puck JM
    Genet Med; 2012 Jan; 14(1):81-9. PubMed ID: 22237435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.
    Tadaki H; Saitsu H; Kanegane H; Miyake N; Imagawa T; Kikuchi M; Hara R; Kaneko U; Kishi T; Miyamae T; Nishimura A; Doi H; Tsurusaki Y; Sakai H; Yokota S; Matsumoto N
    Int J Immunogenet; 2011 Aug; 38(4):287-93. PubMed ID: 21382177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
    Paskiewicz A; Niu J; Chang C
    Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
    Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
    Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome.
    Jevtich K; Price S; Similuk M; Kulm E; Yan J; Setzer M; Jamal L; Franco LM; Ghosh R; Walkiewicz M; Rao VK
    Blood Adv; 2022 Jul; 6(13):3974-3978. PubMed ID: 35476126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome.
    Delgadillo DM; Céspedes-Cruz AI; Ríos-Castro E; Rodríguez Maldonado MG; López-Nogueda M; Márquez-Gutiérrez M; Villalobos-Manzo R; Ramírez-Reyes L; Domínguez-Fuentes M; Tapia-Ramírez J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.